Study reveals novel approach to promote efficient uptake of ASOs into cancer cells

Antisense oligonucleotides (ASOs) are next-generation drugs that can treat disease by blocking the transfer of harmful messages from our genes.

Alzheimer’s Pathology and COVID; Human Brain Cell Maps Unveiled; TCE Ban Proposed

Researchers teased apart possible relationships between COVID-19 and Alzheimer’s disease pathology. (Journal of Neurochemistry) COVID infection was tied to an increased risk of a diagnosis

October 25, 2023

EMA gives thumbs-down to GSK’s multiple myeloma drug, PTC’s Duchenne candidate

Multiple myeloma drug Blenrep and Duchenne muscular dystrophy therapeutic Translarna did not make the European Medicines Agency’s cut for full marketing authorization, the agency announced

September 16, 2023

DOUGLAS Group significantly increased sales and profitability – Biotech Investments

EQS-News: Douglas GmbH / Key word(s): Quarter Results Strong start into the new financial year: DOUGLAS Group significantly increased sales and profitability 15.02.2024 / 07:30

February 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.